SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-040388
Filing Date
2004-03-12
Accepted
2004-03-12 15:04:20
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2003 d10k.htm 10-K 1145838
3 CODE OF ETHICS AND BUSINESS STANDARDS dex14.htm EX-14 67039
4 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 12580
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1559
6 CERTIFICATION OF CEO dex311.htm EX-31.1 10950
7 CERTIFICATION OF CFO dex312.htm EX-31.2 10968
8 CERTIFICATION OF CEO dex321.htm EX-32.1 5524
9 CERTIFICATION OF CFO dex322.htm EX-32.2 5721
  Complete submission text file 0001193125-04-040388.txt   1262594
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 04665844
SIC: 8093 Services-Specialty Outpatient Facilities, NEC